LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Empowering Women Leaders: SHELeads Talk Series at Woxsen University Highlights Urgent Call for Gender Parity
HYDERABAD, India, Sept. 26, 2025 /PRNewswire/ -- Woxsen University's School of Arts &…
Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth
September 26, 2025 16:05 ET | Source: Silynxcom Ltd. Netanya, Israel, Sept.…
Maris-Tech Announces Financial Results for the Six Months Ended June 30, 2025
September 26, 2025 16:04 ET | Source: Maris-Tech Ltd. The company continues…
NYSE Content Advisory: Pre-Market Update + President of South Korea rings Opening Bell
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The New York Stock Exchange…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Glucose Health, Inc. Announces Officer Changes Effective September 30, 2025
September 26, 2025 16:00 ET | Source: Glucose Health BENTONVILLE, Ark., Sept.…
IOC launches revamped Young Reporters Programme for Dakar 2026
26 September 2025 - Applications are now open for the next edition of the Young…
ChainUp Catalyzes Key Dialogue on Digital Assets Regulation with 400 Executives Ahead of TOKEN2049 Singapore
SINGAPORE, Sept. 26, 2025 /PRNewswire/ -- ChainUp, a global leader in digital…
Fruit Attraction 2025 to host the biggest edition in its history
MADRID, Sept. 25, 2025 /PRNewswire/ -- From 30 September to 2 October,…